REDUCED MICROGLIAL ACTIVITY IN THE EARLY STAGES OF AUTOIMMUNE CNS INFLAMMATION LEADS TO ENHANCED GLUTAMATE TRANSMISSION IN THE BASOLATERAL AMYGDALA
Shaona Acharjee (University of Calgary, Canada)

THE BLOOD MENINGEAL BARRIER ORCHESTRATES THE DEVELOPMENT OF AUTOIMMUNE INFLAMMATORY RESPONSES
Jorge Ivan Alvarez (L’université De Montréal, Canada / University Of Pennsylvania, USA)

AGING AND RECURRENT EPISODES OF NEUROINFLAMMATION PROMOTES PROGRESSIVE EAE IN BIOZZI ABH MICE
Sandra Amor (VU University Medical Centre, the Netherlands)

METHYLATION AND EXPRESSION PROFILES OF MONOCYTES IN MONOZYGOTIC TWINS: ROLE IN MYASTHENIA GRAVIS
Nili Avidan (Technion, Israel)

Depletion of CD52+ cells inhibits the development autoimmune encephalomyelitis, but can block the induction of immunological tolerance: Implications for drug-induced secondary autoimmunity in MS
David Baker (Queen Mary University of London, UK)

HUMAN EMBRYONIC STEM CELL -DERIVED OLIGODENDROCYTE PROGENITOR CELLS PROVIDE LONG TERM IMMUNE-REGULATION AND PROTECTION IN A CHRONIC-RELAPSING MODEL OF MULTIPLE SCLEROSIS
Tamir Ben-Hur
(Hadassah Hebrew University Medical Center, Israel)

A NOVEL AUTOANTIBODY FACILITATES BRAIN MICROVASCULAR ENDOTHELIAL PERMEABILITY IN NEUROMYELITIS OPTICA
Jeffrey Bennett (University of Colorado Denver School of Medicine, USA)

GUT MICROBIOTA FROM MULTIPLE SCLEROSIS PATIENTS TRIGGERS AUTOIMMUNE ENCEPHALOMYELITIS IN MICE
Kerstin Berer (Max Planck Institute of Neurobiology, Germany)

CD8 T CELL-MEDIATED KILLING OF OREXINERGIC NEURONS INDUCES A NARCOLEPSY-LIKE PHENOTYPE IN MICE
Raphael Bernard-Valnet (Université De Toulouse III, France)

PRECONDITIONED MSCS TREAT MYASTHENIA GRAVIS IN A HUMANIZED PRECLINICAL MODEL
Sonia Berrih-Aknin (Sorbonne Universités, France)

CHRONIC SPINAL CORD INJURY ATTENUATES INFLUENZA VIRUS SPECIFIC ANTIVIRAL IMMUNITY
John Bethea (Drexel University, USA)

SALL1 DEFINES MICROGLIA FATE AND FUNCTION
Anne Buttgereit (University of Zurich, Switzerland)

MICROVESICLES AS A POSSIBLE BIOMARKER FOR MICROGLIA ACTIVATION IN VIVO DURING PHASES OF DISEASE ACTIVITY IN MULTIPLE SCLEROSIS AND THEIR CORRELATION WITH DIFFERENT STAGES OF DISEASE COURSE
Tommaso Croese (San Raffaele Hospital, Italy)

USE OF TOLL-LIKE RECEPTOR AGONISTS FOR THE DEVELOPMENT OF EXPERIMENTAL MYASTHENIA GRAVIS MODELS WITH THYMIC HYPERPLASIA
Melanie Cron (G.H. Pitie_Salpetriere, France)

CHARACTERIZATION OF THE ROLE OF MIR-150-5P IN MYASTHENIA GRAVIS
Mélanie Cron (AIM, Center of Research in Myology, France)

THE IMMUNOGENICITY OF AMYLOID BETA OLIGOMERS AND ROLE ALONG WITH THEIR IMMUNE COMPLEXES IN MACROPHAGE-MEDIATED INFLAMMATION
Indre Dalgediene (Vilnius University, Lithuania)

TARGETING PLASMA CELLS WITH PROTEASOME INHIBITORS FOR TREATMENT OF MYASTHENIA GRAVIS
Marina Damas (Maastricht University, the Netherlands)

MANIPULATING IFN-I SIGNALING IN THE BRAIN THROUGHOUT LIFE REVEALS A NOVEL HOMEOSTATIC MICROGLIAL REGULATOR
Aleksandra Deczkowska (the Weizmann Institute of Science, Israel)

ASTROCYTE DEFORMATION AND NEUROVASCULAR DISRUPTION MEDIATE NEURONAL INJURY AND CORTICAL DAMAGE IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Raya Eilam (the Weizmann Institute of Science, Israel)

THE HIPPOCAMPUS IS A (PARTIALLY) IMMUNE PRIVILEGED SITE
Nina Fainstein (Hadassah Hebrew University Medical Center, Israel)

INTRATHECAL PLASMA CELLS ARE CLONALLY EXPANDED AND PRODUCE PATHOGENIC ANTIBODIES IN ANTI-NMDA-R ENCEPHALITIS
Norbert Goebels (Heinrich-Heine-University, Germany)

PROTECTIVE EFFECTS OF A PARASITE-DERIVED 68-MER PEPTIDE IN A RELAPSING MOUSE MODEL OF MULTIPLE SCLEROSIS
Judith Greer (The University of Queensland, Australia)

SINGLE NUCLEUS RNA-SEQ REVEALS DYNAMICS OF ADULT NEWBORN NEURONS
Naomi Habib
(MIT and Harvard, USA)

TOWARDS AN IMPROVED CLASSIFICATION OF RELAPSING DEMYELINATING SYNDROMES OF THE CENTRAL NERVOUS SYSTEM IN CHILDREN
Yael Hacohen (Great Ormond Street Hospital for Children, UK)

ONCOSTATIN M SIGNALING IS ESSENTIAL FOR ROBUST REMYELINATION
Niels Hellings (Hasselt University, Belgium)

THE FARNESOID-X-RECEPTOR IN MYELOID CELLS CONTROLS CENTRAL NERVOUS SYSTEM AUTOIMMUNITY IN AN IL-10-DEPENDENT FASHION
Martin Herold (University of Muenster, Germany)

REVIEW OF GAD ANTIBODY ASSAY IN OVER 820 PATIENTS AND ANALYSIS OF CLINICAL PHENOTYPE AND RESPONSE TO IMMUNOTHERAPY IN 15 STIFF PERSON SYNDROME PATIENTS
Saiju Jacob (University Hospitals Birmingham and University of Birmingham, UK)

INTRAVITAL IMAGING OF CALCIUM ACTIVITIES IN THE ENCEPHALITOGENIC T CELLS DURING THEIR JOURNEY TO CNS
Naoto Kawakami (Lmu Munich, Germany)

DOUBLE NEGATIVE (CD19+CD27-IGD-CD20-) B CELLS ARE UP-REGULATED IN AUTO-ANTIBODY ASSOCIATED NEUROLOGICAL DISEASES AND SHOW SIMILIRAITIES TO PLASMABLASTS ON A TRANSCRIPTOME LEVEL
Markus Kowarik (Technische Universitat Muenchen, Germany)

PHOSPHORYLATION OF ALPHAB-CRYSTALLIN SUPPORTS REACTIVE ASTROGLIOSIS IN DEMYELINATION
Hedwich F. Kuipers (Stanford University, USA)

DIFFERENTIAL IMMUNE FUNCTIONS OF MURINE SUBTYPES OF ASTROCYTES
Ehud Lavi (New York Presbyterian Hospital / Cornell University Campus, USA)

B CELL REPERTOIRE EXPANSION OCCURES IN MENINGEAL ECTOPIC LYMPHOID TISSUE
Klaus Lehmann-Horn (University of California, USA)

HIGH DIMENSIONAL ANALYSIS OF THE MYELOID LANDSCAPE IN MULTIPLE SCLEROSIS
Brian Leung (Universität Zürich, Switzerland)

WIRING OR NETWORKING: ANATOMICAL AND FUNCTIONAL CHANGES IN THE VISUAL SYSTEM FOLLOWING OPTIC NEURITIS
Netta Levin (Hadassah Hebrew University Medical Center, Israel)

EFFECT OF MATERNAL ANTIBODIES DIRECTED TO THE ASTROCYTIC WATER CHANNEL PROTEIN AQP4 IN NEUROMYELTIS OPTICA PREGNANCIES
Simone Mader (The Feinstein Institute for Medical Research, USA)

REGULATORY ROLE OF CYTOSOLIC PHOSPHOLIPASE A2 ALPHA IN INDUCTION OF CD40 IN MICROGLIA
Yafa Fetfet Malada-Edelstein (Ben-gurion University Of The Negev And Soroka University Medical Center, Israel)

POSSIBLE ROLE OF MICRORNAS IN THE MODULATION OF NEUROINFLAMMATION BY MESENCHYMAL STEM CELLS
Chiara Marini (Italian Institute of Technology, Italy)

MOLECULAR PROFILING OF DAMAGE AND REPAIR IN THE CSF BY TRANSLATING TRANSCPRITOME DATA TO CSF PROTEOME
Nellie Anne Martin (Odense University Hospital and Institute of Clinical Research, Denmark)

RETINA ATROPHY IS MORE PROMINENT IN THE EARLY PHASES OF MULTIPLE SCLEROSIS AND IS ASSOCIATED WITH CLINICAL DISEASE ACTIVITY: A COHORT STUDY
Elena H. Martinez-Lapiscina (Hospital Clinic of Barcelona, Spain)

BRAIN LESION LOAD AND ANATOMIC DISTRIBUITION IN PATIENTS WITH JUVENILE CLINICALLY ISOLATED SYNDROME PREDICTS RAPID CONVERSION TO MULTIPLE SCLEROSIS
Shay Menascu (Sheba Medical Center, Israel)

THERAPY WITH ECULIZUMAB FOR PATIENTS WITH PRIMARY P.CYS89TYR MUTATION IN THE CD59 GENE
Dror Mevorach (Hebrew University – Hadassah Medical Center, Israel)

IRF4 BUT NOT ROR-GAMMAT IS INDISPENSABLE FOR PATHOGENIC TH17 CELL DEVELOPMENT AND MAINTAINANCE
Ilgiz Mufazalov (the Johannes Gutenberg University, Germany)

A UNIQUE TGFBETA-1-DRIVEN GENOMIC PROGRAM LINKS ASTROCYTOSIS, LOW-GRADE INFLAMMATION AND CHRONIC DEMYELINATION IN THE SPINAL CORD OF MULTIPLE SCLEROSIS
Serge Nataf (University Lyon-1, France)

ASSESSING THE EFFICACY OF A DNA VACCINE AGAINST AMYLOID-Β IN A DOWN-SYNDROME MOUSE MODEL
Eitan Okun (Bar-Ilan University, Israel)

POLY(ADP-RIBOSE) TYPE 1 (PARP) INHIBITION IN LEUKOCYTES DIMINISHES INFLAMMATION VIA EFFECTS ON INTEGRINS/CYTOSKELETON AND PROTECTS THE BLOOD BRAIN BARRIER (BBB)
Yuri Persidsky (Lewis Katz School of Medicine at Temple University, USA)

ALCAM REGULATES B CELLS MIGRATION ACROSS THE BARRIERS OF THE CNS
Alexandre Prat (Université de Montréal, Canada)

AGEING INFLUENCES NADPH-OXIDASE ACTIVATION DURING NEUROINFLAMMATION
Helena Radbruch (Charité - Universitätsmedizin Berlin, Germany)

THE ROLE OF MICROGLIA IN ADULT NEUROGENESIS
Ronen Reshef (The Hebrew University of Jerusalem, Israel)

SUPER-RESOLUTION MICROSCOPY AND LIVE-CELL IMAGING TO REVEAL PROBIOTIC-DENDRITIC CELL INTERACTION
Elena Rinaldi (Neurological Institute Carlo Besta, Italy)

UNDERSTANDING REMYELINATION FAILURE: GM-CSF BLOCKS OLIGODENDROCYTE PROGENITOR CELL DIFFERENTIATION
Andrew Robinson (Northwestern University, USA)

LET-7 MICRORNAS PROTECT BLOOD BRAIN BARRIER (BBB) IN ISCHEMIA/REPERFUSION
Slava Rom (Temple University School of Medicine, USA)

TRANSIENTLY BREAKING IMMUNE TOLERANCE BY TARGETING FOXP3+CD4+ REGULATORY T CELLS MITIGATES ALZHEIMER’S DISEASE PATHOLOGY
Neta Rosenzweig (the Weizmann Institute of Science, Israel)

CELLULAR INVESTIGATIONS WITH HUMAN ANTIBODIES ASSOCIATED WITH THE IGLON5 SYNDROME
Lidia Sabater (Hospital Clinic De Barcelona / Neuroimmunology Group, Spain)

CYLD AGGRAVATES EXPERIMENTAL CEREBRAL MALARIA BY IMPAIRING CD8+ T CELL RESPONSES AND FOSTERING BLOOD-BRAIN BARRIER DAMAGE
Dirk Schlüter (Otto-von-Guericke-University, Germany)

INVESTIGATING THE ROLE OF ASTROCYTES’ ANTI-EXCITOTOXICITY POTENTIAL FOR NEURONAL DAMAGE FORMATION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS – AN IN VIVO TWO-PHOTON IMAGING APPROACH
Volker Siffrin (Charité – Universitatsmedizin Berlin, Germany)

NON- INVASIVE INTRANASAL TREATMENT OF ANGIOTENSIN RELATED DRUGS AS POTENTIAL THERAPY FOR ALZHEIMER’S DISEASE
Nofar Torika-Nadiv (Ben Gurion University of the Negev, Israel)

INDUCTION OF THE TYPE I INTERFERON RESPONSE IN NEUROLOGICAL FORMS OF GAUCHER DISEASE
Einat Vitner (Iibr, Infectious Diseases, Israel)

ABERRANT ACTIVATION OF CLASSICAL COMPLEMENT PATHWAY MEDIATES SYNAPTIC LOSS IN A MOUSE MODEL OF SPINAL MUSCULAR ATROPHY
Aleksandra Vukojicic (Columbia University, USA)

ENGULFMENT OF LIVING TH17 CELLS BY MICROGLIA WITHIN THE BRAIN WITHOUT SUBSEQUENT CELL DEATH
Beatrice Wasser (University Medical Center of the Johannes-Gutenberg University Mainz, Germany)

ANTIPHOSPHOLIPID SYNDROME, ANNEXIN ANTIBODIES AND BEHAVIOR
Ronen Weiss (Tel Aviv University, Israel)

CTLA-4 BLOCKADE ELICITS PARANEOPLASTIC NEUROLOGICAL DISEASE IN A MOUSE MODEL
Lidia Yshii (Inserm U1043, Cptp, Chu Purpan, France)

THE ROLE OF ASTROCYTIC DOPAMINE D2 RECEPTOR IN NEUROINFLAMMATION: IMPLICATION FOR PARKINSON’S DISEASE
Jiawei Zhou (Shanghai Institutes for Biological Sciences, Cina)

PRICKLE1 AS POSITIVE REGULATOR OF LIGODENDROCYTE DIFFERENTIATION
Rina Ilona Zilkha-Falb (Sheba Medical Center, Israel)

Joomla Template by Joomla51.com

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie policy